Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy

Japanese cedar pollinosis is a type I allergic disease and has already become a major public health problem in Japan. Conventional subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) cannot meet patients’ needs owing to the side effects caused by both the use of conventio...

Full description

Bibliographic Details
Main Authors: Qingliang Kong, Kouki Higasijima, Rie Wakabayashi, Yoshiro Tahara, Momoko Kitaoka, Hiroki Obayashi, Yanting Hou, Noriho Kamiya, Masahiro Goto
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/11/11/563
_version_ 1798037990833913856
author Qingliang Kong
Kouki Higasijima
Rie Wakabayashi
Yoshiro Tahara
Momoko Kitaoka
Hiroki Obayashi
Yanting Hou
Noriho Kamiya
Masahiro Goto
author_facet Qingliang Kong
Kouki Higasijima
Rie Wakabayashi
Yoshiro Tahara
Momoko Kitaoka
Hiroki Obayashi
Yanting Hou
Noriho Kamiya
Masahiro Goto
author_sort Qingliang Kong
collection DOAJ
description Japanese cedar pollinosis is a type I allergic disease and has already become a major public health problem in Japan. Conventional subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) cannot meet patients’ needs owing to the side effects caused by both the use of conventional whole antigen molecules in the pollen extract and the administration routes. To address these issues, a surface-modified antigen and transcutaneous administration route are introduced in this research. First, the pollen extract (PE) was conjugated to galactomannan (PE-GM) to mask immunoglobulin E (IgE)-binding epitopes in the PE to avoid side effects. Second, as a safer alternative to SCIT and SLIT, transcutaneous immunotherapy (TCIT) with a solid-in-oil (S/O) nanodispersion system carrying PE-GM was proposed. Hydrophilic PE-GM was efficiently delivered through mouse skin using S/O nanodispersions, reducing the antibody secretion and modifying the type 1 T helper (Th1)/ type 2 T helper (Th2) balance in the mouse model, thereby demonstrating the potential to alleviate Japanese cedar pollinosis.
first_indexed 2024-04-11T21:34:06Z
format Article
id doaj.art-9aa14c118f144bb9b55f8849a58601b8
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-04-11T21:34:06Z
publishDate 2019-10-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-9aa14c118f144bb9b55f8849a58601b82022-12-22T04:01:48ZengMDPI AGPharmaceutics1999-49232019-10-01111156310.3390/pharmaceutics11110563pharmaceutics11110563Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis ImmunotherapyQingliang Kong0Kouki Higasijima1Rie Wakabayashi2Yoshiro Tahara3Momoko Kitaoka4Hiroki Obayashi5Yanting Hou6Noriho Kamiya7Masahiro Goto8Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka 819-0395, JapanDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka 819-0395, JapanDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka 819-0395, JapanDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka 819-0395, JapanDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka 819-0395, JapanDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka 819-0395, JapanSchool of Pharmacy, Shenyang Pharmaceutical University, No.103, Wenhua Road, Shenyang 110016, ChinaDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka 819-0395, JapanDepartment of Applied Chemistry, Graduate School of Engineering, Kyushu University, Fukuoka 819-0395, JapanJapanese cedar pollinosis is a type I allergic disease and has already become a major public health problem in Japan. Conventional subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) cannot meet patients’ needs owing to the side effects caused by both the use of conventional whole antigen molecules in the pollen extract and the administration routes. To address these issues, a surface-modified antigen and transcutaneous administration route are introduced in this research. First, the pollen extract (PE) was conjugated to galactomannan (PE-GM) to mask immunoglobulin E (IgE)-binding epitopes in the PE to avoid side effects. Second, as a safer alternative to SCIT and SLIT, transcutaneous immunotherapy (TCIT) with a solid-in-oil (S/O) nanodispersion system carrying PE-GM was proposed. Hydrophilic PE-GM was efficiently delivered through mouse skin using S/O nanodispersions, reducing the antibody secretion and modifying the type 1 T helper (Th1)/ type 2 T helper (Th2) balance in the mouse model, thereby demonstrating the potential to alleviate Japanese cedar pollinosis.https://www.mdpi.com/1999-4923/11/11/563japanese cedar pollinosisnanocarrierpollen extract-galactomannan conjugatesolid-in-oil nanodispersionstranscutaneous immunotherapyvaccine
spellingShingle Qingliang Kong
Kouki Higasijima
Rie Wakabayashi
Yoshiro Tahara
Momoko Kitaoka
Hiroki Obayashi
Yanting Hou
Noriho Kamiya
Masahiro Goto
Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy
Pharmaceutics
japanese cedar pollinosis
nanocarrier
pollen extract-galactomannan conjugate
solid-in-oil nanodispersions
transcutaneous immunotherapy
vaccine
title Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy
title_full Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy
title_fullStr Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy
title_full_unstemmed Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy
title_short Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy
title_sort transcutaneous delivery of immunomodulating pollen extract galactomannan conjugate by solid in oil nanodispersions for pollinosis immunotherapy
topic japanese cedar pollinosis
nanocarrier
pollen extract-galactomannan conjugate
solid-in-oil nanodispersions
transcutaneous immunotherapy
vaccine
url https://www.mdpi.com/1999-4923/11/11/563
work_keys_str_mv AT qingliangkong transcutaneousdeliveryofimmunomodulatingpollenextractgalactomannanconjugatebysolidinoilnanodispersionsforpollinosisimmunotherapy
AT koukihigasijima transcutaneousdeliveryofimmunomodulatingpollenextractgalactomannanconjugatebysolidinoilnanodispersionsforpollinosisimmunotherapy
AT riewakabayashi transcutaneousdeliveryofimmunomodulatingpollenextractgalactomannanconjugatebysolidinoilnanodispersionsforpollinosisimmunotherapy
AT yoshirotahara transcutaneousdeliveryofimmunomodulatingpollenextractgalactomannanconjugatebysolidinoilnanodispersionsforpollinosisimmunotherapy
AT momokokitaoka transcutaneousdeliveryofimmunomodulatingpollenextractgalactomannanconjugatebysolidinoilnanodispersionsforpollinosisimmunotherapy
AT hirokiobayashi transcutaneousdeliveryofimmunomodulatingpollenextractgalactomannanconjugatebysolidinoilnanodispersionsforpollinosisimmunotherapy
AT yantinghou transcutaneousdeliveryofimmunomodulatingpollenextractgalactomannanconjugatebysolidinoilnanodispersionsforpollinosisimmunotherapy
AT norihokamiya transcutaneousdeliveryofimmunomodulatingpollenextractgalactomannanconjugatebysolidinoilnanodispersionsforpollinosisimmunotherapy
AT masahirogoto transcutaneousdeliveryofimmunomodulatingpollenextractgalactomannanconjugatebysolidinoilnanodispersionsforpollinosisimmunotherapy